Abbott Laboratories (ABT) stock analysis

Abbott Laboratories — Healthcare · Medical Devices carries a Plainview business-quality score of 8.1/10, built deterministically from SEC filings and Yahoo Finance: revenue, margins, cash, valuation, and a confluence buy zone. The live X-Ray loads below.

On the fundamentals, Abbott Laboratories shows trailing revenue of $46.58B, a 56.8% gross margin, net debt of $21.25B, EPS of 3.34, valued at about 4.0x times sales. X-Ray measures business quality only — momentum and entry timing live in Decide and Opportunity Cost.

• Current Price: $108.00
• YTD Return: -13.0%
• Revenue TTM: $46.58B
• Revenue Trend: YoY +7.8%
• Gross Margin: 56.8%
• Net Cash: $-21.25B
• EPS: 3.34
• P/S Ratio: 4.0x

Compare: ABT vs UNH · ABT vs JNJ · ABT vs LLY | Also: UNH, JNJ, LLY, PFE, MRK, ABBV